Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis
JN Lycke, JE Karlsson, O Andersen… - Journal of Neurology …, 1998 - jnnp.bmj.com
The neurofilament protein is a major structural protein of neurons and a marker for axonal
damage. The concentrations of the light subunit of the neurofilament triplet protein (NFL) in …
damage. The concentrations of the light subunit of the neurofilament triplet protein (NFL) in …
IMMUNOSUPPRESSIVE THERAPY REDUCES AXONAL DAMAGE IN PROGRESSIVE MULTIPLE SCLEROSIS
JN Lycke - comtecmed.com
Background: In progressive MS, disease modifying therapies have not been shown to
reduce disability progression. Objective: The impact from immunosuppressive therapy in …
reduce disability progression. Objective: The impact from immunosuppressive therapy in …
Reply to Avasarala
JN Lycke, C Malmeström, S Haghighi, L Rosengren… - 2023 - AAN Enterprises
We thank Dr Avasarala for the comments regarding our study. There are no methodological
problems to measure S-100B or NSE in serum. However, the mechanism by which CNS …
problems to measure S-100B or NSE in serum. However, the mechanism by which CNS …
[CITATION][C] Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS-Reply
JN Lycke, C Malmestrom… - …, 2004 - LIPPINCOTT WILLIAMS & WILKINS …